Researchers discover origin of resistance to lung cancer

For treating cancer, drugs based on molecules known as tyrosine kinase inhibitors are sometimes used. One such tyrosine kinase inhibitor, called osimertinib, has been used to treat EGFR-mutated lung cancer with a certain degree of efficacy.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Researchers discover origin of resistance to lung cancer"

Post a Comment